Clinical Trial Update: NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating NIR-II fluorescence-guided hepatectomy using ICG-Cisplatin nanoprobes for hepatocellular carcinoma and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ICG-Cisplatin nanoprobes

Snippet

Sponsor: West China Hospital | Conditions: Liver Cancer, Adult | EARLY_Phase 1 | Status: RECRUITING